Related references
Note: Only part of the references are listed.Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice
M. Espino et al.
CLINICA CHIMICA ACTA (2015)
Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis
Luisa M. Villar et al.
ANNALS OF NEUROLOGY (2014)
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis
Kelly J. Baldwin et al.
CURRENT OPINION IN NEUROLOGY (2013)
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
Aurelien Marabelle et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Novel therapeutic options and drug targets in MS
Axel Methner et al.
NATURE REVIEWS NEUROLOGY (2013)
L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
Nicholas Schwab et al.
NEUROLOGY (2013)
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation
Joanne L. Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis
Luisa M. Villar et al.
ARCHIVES OF NEUROLOGY (2012)
TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection
Sara Yousef et al.
JOURNAL OF IMMUNOLOGY (2012)
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
Maria Jose Magraner et al.
NEURORADIOLOGY (2012)
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Gary Bloomgren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome
Sarah Gheuens et al.
JOURNAL OF VIROLOGY (2011)
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring
Ludwig Kappos et al.
LANCET NEUROLOGY (2011)
Induction of immune tolerance in the treatment of rheumatoid arthritis
Salvatore Albani et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
Erika Irie et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands
I. Bosca et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands
I. Bosca et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Effective use of JC virus PCR for diagnosis of progressive multifocal leukoencephalopathy
Yihong Wang et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
M. Thangarajh et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
The immunopathology of multiple sclerosis:: An overview
Hans Lassmann et al.
BRAIN PATHOLOGY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
TA Yousry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy
RA Du Pasquier et al.
BRAIN (2004)
An ultrasensitive method for the detection of oligoclonal IgG bands
MC Sadaba et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
New insights into progressive multifocal leukoencephalopathy
IJ Koralnik
CURRENT OPINION IN NEUROLOGY (2004)
Requirement for CD4 T cell help in generating functional CD8 T cell memory
DJ Shedlock et al.
SCIENCE (2003)